Glenmark Generics, the U.S. subsidiary of Glenmark Pharmaceuticals, announced that US FDA has granted final ANDA approval for Moexipril Hydrochloride and Hydrochlorothiazide tablets, the generic version of Schwarz Pharmaceuticals' Uniretic.
Moexipril Hydrochloride belongs to a class of drugs considered as ACE inhibitors. Glenmark's combination product of Moexipril Hydrochloride plus the diuretic hydrochlorothiazide is indicated for treatment of patients with hypertension. The annual sales of this combination during the 12-month period ending December 2009 is $ 8 million as per IMS data.
For comments and feedback: editorial@rttnews.com